VANCOUVER, May 5, 2017 /CNW/ - INVICTUS MD
STRATEGIES CORP. ("Invictus MD" or the "Company")
(TSXV: IMH; OTC: IVITF; FRA: 8IS) Invictus MD is pleased to
announce that its management team will visit TSX Venture Exchange
(TSXV) on May 5, 2017 and will be
opening the trading day.
"When we open the trading day, we share this celebration with
all those who have contributed to our success - especially our
team, the board, advisers and investors," said Dan Kriznic,
Executive Chairman of Invictus MD. "From our early beginnings
three years ago, with a clear goal and the desire to do something
remarkable within this budding marketplace, we raised sufficient
capital to make investment commitments for the construction of a
number of cannabis production facilities across Canada. We
have always taken pride in knowing we're working towards becoming a
source of uncompromising quality of medical cannabis and to be
ready for the future new recreational market upon legalization.
Now, three years later, we're thrilled to be on Bay
Street."
"The Company is poised for a tremendous amount of production
profile growth and other value-generating milestones in the near
future. Cultivation has started at Acreage Pharms, having
received their license to cultivate under the Access to Cannabis
for Medical Purposes Regulations ("ACMPR")," stated Trevor Dixon, President and CEO of Invictus MD.
"Planning the Phase II build out has begun; the 150 acre land
package provides the capability to construct facilities to keep
pace with the growing medical cannabis market and meet the demand
that the coming adult recreational cannabis use will create.
AB Laboratories Inc. ("AB Labs"), a Licensed Producer under ACMPR,
is on schedule to meet full production capacity by the end of May
2017. AB Ventures Inc. ("AB Ventures"), an incorporated
company formed to develop a second licensed expansion facility
through its common ownership with AB Labs, closed its 100-acre land
acquisition on May 1, 2017 and once
licensed under the ACMPR, will be used for future cannabis
cultivation.
Considering the magnitude of AB Ventures' land holdings and
future production facilities, and assuming AB Ventures obtains a
license to produce the quantity forecasted for the proposed
facility, we will have the capacity for significant growth to keep
pace with the growing medical and future recreational demand."
About Invictus MD Strategies Corp.
Invictus MD Strategies Corp., Canada's Cannabis Company, is focused on three
main verticals within the burgeoning Canadian cannabis sector:
Licensed Producers under the ACMPR including investment in the
fully licensed facilities operated by AB Laboratories Inc. and
Acreage Pharms Ltd.; Fertilizer and Nutrients through Future
Harvest Development Ltd.; and Cannabis Data and Delivery, with its
wholly owned subsidiary Poda Technologies Ltd.
For more information, please visit www.invictus-md.com.
On Behalf of the Board,
Dan Kriznic
Executive Chairman
Larry Heinzlmeir
Vice President, Marketing & Communications
604-537-8676
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: This
release includes certain statements and information that may
constitute forward-looking information within the meaning of
applicable Canadian securities laws or forward-looking statements
within the meaning of the United States Private Securities
Litigation Reform Act of 1995. All statements in this news release,
other than statements of historical facts, including statements
regarding future estimates, plans, objectives, assumptions or
expectations of future performance, including the Company's
anticipated revenue, the value of the cannabis market in the future
as stated by Deloitte, the potential production capacity of the AB
Labs, AB Ventures and Acreage Pharms' production facilities, the
granting of regulatory approval and anticipated timing of AB Labs
reaching full production capacity, the granting of a license under
the ACMPR to AB Ventures, the success and timing of AB Ventures
acquisition of 100-acre of land are forward-looking statements and
contain forward-looking information. Generally, forward-looking
statements and information can be identified by the use of
forward-looking terminology such as "intends" or "anticipates", or
variations of such words and phrases or statements that certain
actions, events or results "may", "could", "should", "would" or
"occur". Forward-looking statements are based on certain material
assumptions and analysis made by the Company and the opinions and
estimates of management as of the date of this press release,
including the assumptions that recreational use of cannabis will be
legalized, AB Labs, AB Ventures and Acreage Pharms will receive
regulatory approval to produce cannabis at their production
facilities' full capacity, AB Ventures will be granted a license
under the ACMPR, AB Ventures is able to successfully negotiate and
close the 100-acre land acquisition, AB Ventures is able to
successfully build a production facility. These forward-looking
statements are subject to known and unknown risks, uncertainties
and other factors that may cause the actual results, level of
activity, performance or achievements of the Company to be
materially different from those expressed or implied by such
forward-looking statements or forward-looking information.
Important factors that may cause actual results to vary, include,
without limitation, the risk that recreational use of cannabis will
not be legalized, AB Labs and Acreage Pharms will not receive
regulatory approval to produce cannabis at their production
facilities' full production capacity, AB Ventures will not be
granted a license under the ACMPR, AB Ventures is not able to
successfully negotiate and close the 100-acre land acquisition, AB
Ventures is not able to successfully build a production facility.
Although management of the Company has attempted to identify
important factors that could cause actual results to differ
materially from those contained in forward-looking statements or
forward-looking information, there may be other factors that cause
results not to be as anticipated, estimated or intended. There can
be no assurance that such statements will prove to be accurate, as
actual results and future events could differ materially from those
anticipated in such statements. Accordingly, readers should not
place undue reliance on forward-looking statements and
forward-looking information. Readers are cautioned that reliance on
such information may not be appropriate for other purposes. The
Company does not undertake to update any forward-looking statement,
forward-looking information or financial out-look that are
incorporated by reference herein, except in accordance with
applicable securities laws. We seek safe harbor.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
SOURCE Invictus MD Strategies